Dr Sigrun Hallmeyer Highlights Clinical Achievements and Barriers in Melanoma
August 24th 2022In this interview with The American Journal of Managed Care®, Sigrun Hallmeyer, MD, medical director of Advocate Lutheran General Hospital’s Cancer Service Line and co-director of medical research at Advocate Aurora Health, in Illinois, touches on several important topics within the melanoma space.
Five Additional States, Territories Join Medicaid’s Money Follows the Person Program
August 24th 2022Medicaid’s Money Follows the Person (MFP) demonstration program, which began in 2008, has helped states transition more than 107,000 people to community settings rather than living in institutional facilities.
What We’re Reading: Premature Death Risk Factors; Pfizer Vaccine Efficacy; CVD Symptom Disparities
August 24th 2022People who experienced childhood poverty and other adversities are at greater risk of premature death in adulthood; Pfizer’s COVID-19 vaccine is 73% effective in protecting children younger than 5 years; women experience more symptoms of heart failure and other cardiovascular diseases than men.
What We're Reading: OTC Hearing Aids; Respiratory Devices Failing; Postpartum Medicaid Extended
August 17th 2022A new FDA rule will allow hearing aids to be purchased without prescriptions; the FDA has received more than 48,000 reports of faulty Philips respiratory devices between May and July; HHS has extended postpartum Medicaid in Hawaii, Maryland, and Ohio.
Fakhri Reviews Considerations for Second-Line Therapy in DLBCL
August 16th 2022Nearly 5 years after approval of the first CAR T-cell therapy, treatment is moving into second line, and patients have more options than ever for diffuse large B-cell lymphoma. How do physicians choose? Bita Fakhri, MD, MPH, hematologist-oncologist at the University of California San Francisco, discusses the process.
What We're Reading: Drug Pricing Debate; Judge Rules Against Walgreens; Predicting TBI Outcomes
August 11th 2022Policy observers and industry stakeholders debate the possible spillover effects of Medicare drug pricing reform in the employer-based insurance market; a California federal judge rules Walgreens could be held liable for not investigating suspicious orders of opioids in San Francisco; a blood test performed the day of a traumatic brain injury (TBI) can predict which patients may die and who may survive with a disability.
What We’re Reading: Alzheimer Drug Setback; Rural Health Care Investment; Monkeypox Drug Delivery
August 10th 2022Acadia Pharmaceuticals’ pimavanserin (Nuplazid) was not extended by the FDA to include Alzheimer-related psychosis; HHS/Health Resources and Service Administration vow to strengthen rural health care; a new deal has the United States paying $26 million for Siga Technologies’ Tpoxx.